Literature DB >> 2294483

Endoscopic third ventriculostomy.

R F Jones1, W A Stening, M Brydon.   

Abstract

Long-term extracranial shunting for hydrocephalus has numerous drawbacks related to shunt malfunction and infection. In some cases outcome has been very disappointing. We successfully managed 5 patients with acquired aqueductal stenoses with no significant morbidity by the use of an intracranial cerebrospinal fluid diversion, namely a third ventriculostomy. First advocated by Dandy, ventriculostomy was largely passed over in favor of extracranial procedures. With improved surgical techniques, however, ventriculostomy is now considered to be a viable alternative in selected cases. In a further 19 patients, we subsequently broadened our patient selection to include those with Arnold-Chiari malformations, congenital noncommunicating hydrocephalus, and tumors. Two thirds of these children remain without shunts and apart from 1 child developing hemiplegia postoperatively, there has been no significant morbidity. Although the best results have been seen in the late onset groups, even early onset, noncommunicating hydrocephalus has been successfully managed. Even in patients in whom third ventriculostomy has failed and who have subsequently required ventriculoperitoneal shunts, we anticipate that they will remain less dependent on shunts because their hydrocephalus is now communicating, which tends not to have such a rapid onset or extreme levels of raised intracranial pressure.

Entities:  

Mesh:

Year:  1990        PMID: 2294483     DOI: 10.1097/00006123-199001000-00012

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  53 in total

Review 1.  Long-term complications and definition of failure of neuroendoscopic procedures.

Authors:  Tjemme Beems; J Andre Grotenhuis
Journal:  Childs Nerv Syst       Date:  2004-06-10       Impact factor: 1.475

2.  Endoscopic neurosurgery.

Authors:  J H Neal
Journal:  West J Med       Date:  1990-11

3.  Endoscopic third ventriculostomy before tumor surgery in children with posterior fossa tumors, CCHE experience.

Authors:  Mohamed Ahmed El Beltagy; Hazem Mostafa Kamal; Hala Taha; Madeha Awad; Nada El Khateeb
Journal:  Childs Nerv Syst       Date:  2010-05-26       Impact factor: 1.475

Review 4.  Use of endoscopic third ventriculostomy in hydrocephalus of tubercular origin.

Authors:  Sanat Bhagwati; Nirav Mehta; Suneel Shah
Journal:  Childs Nerv Syst       Date:  2010-05-28       Impact factor: 1.475

Review 5.  Success and failure of endoscopic third ventriculostomy in young infants: are there different age distributions?

Authors:  Dorothee Koch-Wiewrodt; Wolfgang Wagner
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

6.  Hemodynamic and electrolyte changes in patients undergoing neuroendoscopic procedures.

Authors:  Abdürrahim Derbent; Yusuf Erşahin; Taşkin Yurtseven; Tuncer Turhan
Journal:  Childs Nerv Syst       Date:  2005-09-23       Impact factor: 1.475

7.  Simultaneous endoscopic third ventriculostomy and ventriculoperitoneal shunt for infantile hydrocephalus.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-11-10       Impact factor: 1.475

Review 8.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

9.  Effect of endoscopic third ventriculostomy on neuropsychological outcome in late onset idiopathic aqueduct stenosis: a prospective study.

Authors:  J Burtscher; L Bartha; K Twerdy; W Eisner; T Benke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  Endoscopic third ventriculostomy: the best option in the treatment of persistent hydrocephalus after posterior cranial fossa tumour removal?

Authors:  G Tamburrini; B L Pettorini; L Massimi; M Caldarelli; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2008-09-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.